
HMGB1 Inhibition Alleviates Chronic Nonbacterial Prostatitis by Suppressing M1 Polarization of Macrophages
Introduction Prostatitis is among the most frequently encountered conditions in urological practice. According to epidemiological data, the prevalence of prostatitis-like symptoms ranges from 2.2% to 9.7%, with an average incidence rate of 8.2%.1 According …